Lidocaine/tetracaine medicated plaster: In minor dermatological and needle puncture procedures

Drugs

Volumn 70, Issue 16, 2010, Pages 2113-2120

  Croxtall, Jamie D ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

Adis Drug Profiles; Lidocainetetracaine, general; Pain; Topical

Indexed keywords

AMIODARONE; DISOPYRAMIDE; EMLA; LIDOCAINE; LIDOCAINE PLUS TETRACAINE; MEXILETINE; QUINIDINE; TETRACAINE; TOCAINIDE; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL;

ANALGESIA; ANTIVIRAL ACTIVITY; APPLICATION SITE REACTION; BACTERICIDAL ACTIVITY; BURNING SENSATION; CANNULATION; CLINICAL TRIAL; CONTACT DERMATITIS; CRYOTHERAPY; DERMATOLOGICAL PROCEDURES; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG TOLERABILITY; DRUG TOLERANCE; EDEMA; ERYTHEMA; GAUZE DRESSING; HUMAN; IMMUNIZATION; LIVER METABOLISM; LOW LEVEL LASER THERAPY; MAXIMUM PLASMA CONCENTRATION; MEDICATED PLASTER; NEEDLE; NEEDLE PUNCTURE PROCEDURE; PAIN; PAIN ASSESSMENT; PLASTER CAST; PRESCRIPTION; PRURITUS; PUNCH BIOPSY; RASH; REVIEW; SCORING SYSTEM; SELF REPORT; SIDE EFFECT; SKIN BIOPSY; SKIN DISCOLORATION; SKIN PIGMENTATION; TASTE AVERSION; URTICARIA; VASCULAR ACCESS; VEIN PUNCTURE; VISUAL ANALOG SCALE;

EID: 77958526533     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/11206390-000000000-00000     Document Type: Review

References (24)

1. Kennedy RM, Luhmann JD. Pharmacological managementof pain and anxiety during emergency procedures in children. Paediatr Drugs 2001; 3 (5): 337-54
2. Gunter JB. Benefit and risks of local anesthetics in infantsand children. Paediatr Drugs 2002; 4 (10): 649-72
3. Pesaturo KA, Matthews M. Topical anesthesia use in chil-dren. US Pharm 2009; 34 (3): HS-4-7
4. Shainhouse T, Cunningham B. Topical anesthetics: physio-logy, formulations, and novel delivery systems. Am J Drug Deliv 2004; 2 (2): 89-99
5. Zempsky WT. Pharmacologic approaches for reducing venousaccess pain in children. Pediatrics 2008; 122 Suppl. 3: S140-53
6. Ball AM, Smith KM. Optimizing transdermal drug therapy.Am J Health Syst Pharm 2008; 65 (14): 1337-46
7. Eurocept International. Rapydan 70mg/70mg medicatedplaster: summary of product characteristics [online]. Available from URL: http://www. lakemedelsverket.se/SPC-PIL/ Pdf/enhumspc/Rapydan %20medicated%20patch%20ENG. pdf [Accessed 2010 Aug 5]
8. Zars Pharma Inc. Synera® (lidocaine 70 mg/tetracaine 70 mg)topical patch: US prescribing information [online]. Available from URL: http://www.synera.com/PDFs/Synera-PI.pdf [Accessed 2010 Aug 5]
9. Comer AM, Lamb HM. Lidocaine patch 5%. Drugs 2000;59 (2): 245-9; discussion 250-1
10. Garnock-Jones KP, Keating GM. Lidocaine 5% medicated plaster: a review of its use in postherpetic neuralgia. Drugs 2009; 69 (15): 2149-65
11. O'Brien L, Taddio A, Lyszkiewicz DA, et al. A critical re-view of the topical local anesthetic amethocaine (Ametop) for pediatric pain. Paediatr Drugs 2005; 7 (1): 41-54
12. Cada DJ, Arnold B, Levien T, et al. Lidocaine/tetracainepatch. Hosp Pharm 2006; 41 (3): 265-73
13. Sheets MF, Hanck DA. Outward stabilization of the S4segments in domains III and IV enhances lidocaine block of sodium channels. J Physiol 2007; 582 (Pt 1): 317-34
14. Li HL, Galue A, Meadows L, et al. A molecular basis for thedifferent local anesthetic affinities of resting versus open and inactivated states of the sodium channel. Mol Pharmacol 1999; 55 (1): 134-41
15. Shomaker TS, Zhang J, Love G, et al. Evaluating skin an-esthesia after administration of a local anesthetic system consisting of an S-Caine patch and a controlled heat-aided drug delivery (CHADD) patch in volunteers. Clin J Pain 2000; 16 (3): 200-4
16. Berman B, Flores J, Pariser D, et al. Self-warming lidocaine/tetracaine patch effectively and safely induces local anesthesia during minor dermatologic procedures. Dermatol Surg 2005; 31 (2): 135-8
17. Schecter AK, Pariser DM, Pariser RJ, et al. Randomized,double-blind, placebo-controlled study evaluating the lidocaine/tetracaine patch for induction of local anesthesia prior to minor dermatologic procedures in geriatric patients. Dermatol Surg 2005; 31 (3): 287-91
18. Curry SE, Finkel JC. Use of the Synera patch for local an-esthesia before vascular access procedures: a randomized, double-blind, placebo-controlled study. Pain Med 2007; 8 (6): 497-502
19. Masud S, Wasnich RD, Ruckle JL, et al. Contribution of aheating element to topical anesthesia patch efficacy prior to vascular access: results from two randomized, double-blind studies. J Pain Symptom Manage. In Press
20. Sawyer J, Febbraro S, Masud S, et al. Heated lidocaine/tetracaine patch (Synera, Rapydan) compared with lido-caine/prilocaine cream (EMLA) for topical anaesthesia before vascular access. Br J Anaesth 2009; 102 (2): 210-5
21. George RB, Habib AS, Allen TK, et al. Brief report: a ran-domized controlled trial of Synera™ versus lidocaine for epidural needle insertion in labouring parturients. Can J Anesth 2008; 55 (3): 168-71
22. Singer AJ, Taira BR, Chisena EN, et al. Warm lidocaine/tetracaine patch versus placebo before pediatric intravenous cannulation: a randomized controlled trial. Ann Emerg Med 2008; 52 (1): 41-7
23. Sethna NF, Verghese ST, Hannallah RS, et al. A random-ized controlled trial to evaluate S-Caine patch for reducing pain associated with vascular access in children. Anesthesiology 2005; 102 (2): 403-8
24. Soltesz S, Dittrich K, Teschendorf P, et al. Topical anesthe-sia before vascular access in children: comparison of a warmth-producing lidocaine-tetracaine patch with a lidocaine-prilocaine patch. Anaesthesist 2010; 59 (6): 519-23